# Altimmune, Inc. (ALT) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $41,000 |
| 2024 | $20,000 |
| 2023 | $426,000 |
| 2022 | -$68,000 |
| 2021 | $4M |
| 2020 | $8M |
| 2019 | $6M |
| 2018 | $10M |
| 2017 | $11M |
| 2016 | $3M |
| 2011 | $24M |
| 2010 | $21M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2025-09-30 | $5,000 |
| 2025-06-30 | $5,000 |
| 2025-03-31 | $5,000 |
| 2024-09-30 | $5,000 |
| 2024-06-30 | $5,000 |
| 2024-03-31 | $5,000 |
| 2023-09-30 | $362,000 |
| 2023-06-30 | $6,000 |
| 2023-03-31 | $21,000 |
| 2022-09-30 | $2,000 |
| 2022-06-30 | $8,000 |
| 2022-03-31 | $32,000 |
| 2021-09-30 | $158,000 |
| 2021-06-30 | $137,000 |
| 2021-03-31 | $838,000 |
| 2020-09-30 | $3M |
| 2020-06-30 | $721,636 |
| 2020-03-31 | $2M |
| 2019-09-30 | $643,978 |
| 2019-06-30 | $2M |
| 2019-03-31 | $3M |
| 2018-09-30 | $3M |
| 2018-06-30 | $2M |
| 2018-03-31 | $3M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALT/revenue)
